279 related articles for article (PubMed ID: 23432628)
1. Targeting cytokines: production and characterization of anti-TNF-α scFvs by phage display technology.
Abdolalizadeh J; Nouri M; Zolbanin JM; Barzegari A; Baradaran B; Barar J; Coukos G; Omidi Y
Curr Pharm Des; 2013; 19(15):2839-47. PubMed ID: 23432628
[TBL] [Abstract][Full Text] [Related]
2. Downstream characterization of anti-TNF-α single chain variable fragment antibodies.
Abdolalizadeh J; Nouri M; Zolbanin JM; Baradaran B; Barzegari A; Omidi Y
Hum Antibodies; 2012; 21(1-2):41-8. PubMed ID: 22885959
[TBL] [Abstract][Full Text] [Related]
3. Selection of potential therapeutic human single-chain Fv antibodies against cholecystokinin-B/gastrin receptor by phage display technology.
Tohidkia MR; Asadi F; Barar J; Omidi Y
BioDrugs; 2013 Feb; 27(1):55-67. PubMed ID: 23344946
[TBL] [Abstract][Full Text] [Related]
4. Phage antibody library screening for the selection of novel high-affinity human single-chain variable fragment against gastrin receptor: an in silico and in vitro study.
Jalilzadeh-Razin S; Mantegi M; Tohidkia MR; Pazhang Y; Pourseif MM; Barar J; Omidi Y
Daru; 2019 Jun; 27(1):21-34. PubMed ID: 30607886
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the novel anti-TNF-α single-chain fragment antibodies using experimental and computational approaches.
Pourtaghi-Anvarian S; Mohammadi S; Hamzeh-Mivehroud M; Alizadeh AA; Dastmalchi S
Prep Biochem Biotechnol; 2019; 49(1):38-47. PubMed ID: 30735094
[TBL] [Abstract][Full Text] [Related]
6. Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. A potential strategy to enhance anti-TNF therapy.
Hristodorov D; Mladenov R; Brehm H; Fischer R; Barth S; Thepen T
MAbs; 2014; 6(5):1283-9. PubMed ID: 25517313
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of a novel scFv antibody fragments specific for Hsp70 as a tumor biomarker.
Vostakolaei MA; Molavi O; Hejazi MS; Kordi S; Rahmati S; Barzegari A; Abdolalizadeh J
J Cell Biochem; 2019 Sep; 120(9):14711-14724. PubMed ID: 30998271
[TBL] [Abstract][Full Text] [Related]
8. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
[TBL] [Abstract][Full Text] [Related]
9. Preparation of single chain variable fragment of MG(7) mAb by phage display technology.
Yu ZC; Ding J; Nie YZ; Fan DM; Zhang XY
World J Gastroenterol; 2001 Aug; 7(4):510-4. PubMed ID: 11819819
[TBL] [Abstract][Full Text] [Related]
10. [Preparation of human phage antibodies specific for SSA/Ro antigen and its sequence analysis].
Li YJ; Peng JM; Zhang FC
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1904-8. PubMed ID: 15631804
[TBL] [Abstract][Full Text] [Related]
11. Cloning and expression of human V-genes derived from phage display libraries as fully assembled human anti-TNF alpha monoclonal antibodies.
Mahler SM; Marquis CP; Brown G; Roberts A; Hoogenboom HR
Immunotechnology; 1997 Mar; 3(1):31-43. PubMed ID: 9154466
[TBL] [Abstract][Full Text] [Related]
12. Altered specificity of single-chain antibody fragments bound to pandemic H1N1-2009 influenza virus after conversion of the phage-bound to the soluble form.
Kaku Y; Noguchi A; Okutani A; Inoue S; Tanabayashi K; Yamamoto Y; Hotta A; Suzuki M; Sugiura N; Yamada A
BMC Res Notes; 2012 Sep; 5():483. PubMed ID: 22943792
[TBL] [Abstract][Full Text] [Related]
13. Identification of Novel Single Chain Fragment Variable Antibodies Against TNF-α Using Phage Display Technology.
Alizadeh AA; Hamzeh-Mivehroud M; Dastmalchi S
Adv Pharm Bull; 2015 Dec; 5(Suppl 1):661-6. PubMed ID: 26793613
[TBL] [Abstract][Full Text] [Related]
14. A rapid novel strategy for screening of antibody phage libraries for production, purification, and functional characterization of amber stop codons containing single-chain antibody fragments.
Perween R; Ahmed S; Shrivastava T; Parray HA; Singh B; Pindari KS; Sharma C; Shukla S; Sinha S; Panchal AK; Kumar R
Biotechnol Prog; 2021 May; 37(3):e3136. PubMed ID: 33620776
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effect of novel internalized fully human phage antibody fragments on proliferation of lung adenocarcinoma cell line overexpressing peroxiredoxin I].
Luo Y; Pang H; Li SJ; Cao H; Li SL; Fan CB
Ai Zheng; 2009 Oct; 28(10):1061-6. PubMed ID: 19799814
[TBL] [Abstract][Full Text] [Related]
16. A comparison of three strategies for biopanning of phage-scFv library against diphtheria toxin.
Lakzaei M; Rasaee MJ; Fazaeli AA; Aminian M
J Cell Physiol; 2019 Jun; 234(6):9486-9494. PubMed ID: 30417355
[TBL] [Abstract][Full Text] [Related]
17. Application of a synthetic phage antibody library (ETH-2) for the isolation of single chain fragment variable (scFv) human antibodies to the pathogenic isoform of the hamster prion protein (HaPrPsc).
Ascione A; Flego M; Zamboni S; De Cinti E; Dupuis ML; Cianfriglia M
Hybridoma (Larchmt); 2005 Jun; 24(3):127-32. PubMed ID: 15943559
[TBL] [Abstract][Full Text] [Related]
18. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei.
Kim HS; Tsai S; Zou N; Lo SC; Wear DJ; Izadjoo MJ
J Immunol Methods; 2011 Feb; 365(1-2):101-9. PubMed ID: 21172353
[TBL] [Abstract][Full Text] [Related]
19. Selection of affinity-improved neutralizing human scFv against HBV PreS1 from CDR3 VH/VL mutant library.
Chen Y; Bai Y; Guo X; Wang W; Zheng Q; Wang F; Sun D; Li D; Ren G; Yin J
Biologicals; 2016 Jul; 44(4):271-275. PubMed ID: 27255707
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of phage display-derived anti-toxin antibodies neutralizing TcdA and TcdB of
Raeisi H; Azimirad M; Asadzadeh Aghdaei H; Zarnani AH; Abdolalizadeh J; Yadegar A; Zali MR
Microbiol Spectr; 2023 Sep; 11(5):e0531022. PubMed ID: 37668373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
